Fiscal Year: January - December
Zoetis Inc. (ZTS), listed on the NYSE, has a market capitalization of $33.04B. As of Jun 08, 2026, the stock is trading at $78.82 per share@else an unavailable price , offering investors a clear view of its current market value. Zoetis Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 13.01, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Zoetis Inc. also offers a dividend yield of 2.69%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Zoetis Inc. (ZTS) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Zoetis Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Zoetis Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Zoetis Inc. is 14.66, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Zoetis Inc. (ZTS) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Zoetis Inc. (ZTS) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Zoetis Inc. (ZTS) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Zoetis Inc.. To access the full SS Score, consider upgrading your subscription.
Zoetis Inc. is a significant player in the industry sector, with a market capitalization of $33.04B and a competitive P/E ratio of 13.01. Investors should compare these metrics with industry peers to gauge whether Zoetis Inc. is outperforming or underperforming within its sector.
Options volume is surging for Zoetis as traders look for potential stock market winners in light of a screwworm case in Texas.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis published its 2025 Sustainability Report, highlighting progress achieved in 2025 through its Driven to Care strategy. This report marks...
Philadelphia, Pennsylvania--(Newsfile Corp. - May 31, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Zoetis, Inc. (NYSE: ZTS).
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquire...
Argus analyst Jasper Hellweg downgraded Zoetis (ZTS) to Hold from Buy.
As previously reported, Argus downgraded Zoetis (ZTS) to Hold from Buy. The firm cites the company’s stock price experiencing a dramatic decline of 22% in a single-day and further losses…
Bearish flow noted in Zoetis (ZTS) with 4,490 puts trading, or 1.4x expected. Most active are Jun-26 85 calls and Jul-26 65 puts, with total volume in those strikes near…
Stifel lowered the firm’s price target on Zoetis (ZTS) to $95 from $105 and keeps a Hold rating on the shares. Zoetis’ revised 2026 guidance implies things improve, yet near-term…
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that a representative of the company will participate in fireside chats at the following investor confe...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the third quarter of 2026. The dividend will b...
Big Short investor Michael Burry is aggressively reallocating capital toward beaten-down stocks, warning the artificial intelligence (AI) boom increasingly resembles the dot-com era. According to him,...
Citi lowered the firm’s price target on Zoetis (ZTS) to $112 from $145 and keeps a Buy rating on the shares. The firm cut the company’s estimates following the “difficult”…
Morgan Stanley analyst Erin Wright lowered the firm’s price target on Zoetis (ZTS) to $115 from $160 and keeps an Overweight rating on the shares.
UBS lowered the firm’s price target on Zoetis (ZTS) to $99 from $130 and keeps a Neutral rating on the shares.
Stifel lowered the firm’s price target on Zoetis (ZTS) to $105 from $130 and keeps a Hold rating on the shares.
JPMorgan lowered the firm’s price target on Zoetis (ZTS) to $130 from $190 and keeps an Overweight rating on the shares.
Futures are higher this morning, helped by another sharp decline in oil prices on optimism around a potential U.S.-Iran framework agreement. Crude dropping back toward the low-$90s is relieving pressu...
Stifel notes that Zoetis (ZTS) Q1 organic operational revenue growth was flat versus the firm’s forecast for 2.4% growth and the Street’s 2.2% expectation. However, Zoetis’ results benefited from a…
The animal-health company missed first-quarter earnings estimates.
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 2.55B | Analyst x3 | |
| 2027 | 3.09B | 20.86% | Analyst x4 |
| 2028 | 3.27B | 6.00% | Analyst x4 |
| 2029 | 3.43B | 4.98% | Analyst x2 |
| 2030 | 3.59B | 4.62% | Analyst x2 |
| 2031 | 3.70B | 2.98% | Est @3.0% |
| 2032 | 3.81B | 2.88% | Est @2.9% |
| 2033 | 3.91B | 2.81% | Est @2.8% |
| 2034 | 4.01B | 2.58% | Est @2.6% |
| 2035 | 4.12B | 2.55% | Est @2.5% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | 2.30B | 1.00 | 2.30B |
| 2025A | 2.28B | 1.00 | 2.28B |
| 2026E | 2.55B | 1.08 | 2.36B |
| 2027E | 3.09B | 1.17 | 2.64B |
| 2028E | 3.27B | 1.26 | 2.59B |
| 2029E | 3.43B | 1.37 | 2.51B |
| 2030E | 3.59B | 1.48 | 2.43B |
| 2031E | 3.70B | 1.60 | 2.31B |
| 2032E | 3.81B | 1.73 | 2.20B |
| 2033E | 3.91B | 1.87 | 2.09B |
| 2034E | 4.01B | 2.02 | 1.99B |
| 2035E | 4.12B | 2.18 | 1.88B |
| Terminal | 74.98B | 2.18 | 34.33B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.
